Definitive Healthcare Corp. Announces Director Resignation: Key Details for Investors

Overview

Definitive Healthcare Corp. (NASDAQ: DH) has filed a Form 8-K with the U.S. Securities and Exchange Commission, dated March 30, 2026, that details a significant boardroom change. This current report focuses on the resignation of a director and related committee membership changes, which may be of importance to shareholders and could have price-sensitive implications.

Key Points from the Report

• Director Resignation: On March 30, 2026, Jeff Haywood resigned from the Board of Directors (the “Board”) of Definitive Healthcare Corp. This resignation also extends to his role as a member of the Human Capital Management and Compensation Committee (the “Compensation Committee”).
• No Other Written Communications: The filing explicitly states that this 8-K does not include written communications pursuant to Rule 425 under the Securities Act, nor is it filed as soliciting material or as pre-commencement tender offer communications.
• Corporate Information: Definitive Healthcare Corp. remains incorporated in Delaware (DE) and is classified under the Services-Prepackaged Software sector (SIC 7372), with its principal executive office located at 492 Old Connecticut Path, Suite 401, Framingham, MA 01701. The company’s trading symbol is DH and its Class A Common Stock (\$0.001 par value) is listed on the Nasdaq Stock Market LLC.
• Emerging Growth Company Status: The company is not classified as an emerging growth company, and it has not opted for the extended transition period for complying with new or revised financial accounting standards.

Shareholder Considerations and Potential Price Sensitivity

• Board Change May Affect Corporate Governance: The resignation of Jeff Haywood from both the Board and the Compensation Committee is significant. Board and committee composition changes can impact executive oversight, compensation policies, and strategic direction, all of which may influence investor confidence and share value.
• Implications for Human Capital and Compensation Oversight: Haywood’s departure from the Compensation Committee may lead to a shift in how the company approaches employee compensation, benefits, and talent retention. Investors should monitor for additional updates regarding committee reassignments or new appointments, as these can affect company performance and culture.
• No Immediate Financial Impact Disclosed: The filing does not report any material financial transactions, earnings updates, or mergers related to this event. However, director resignations can sometimes precede strategic changes or signal internal company dynamics that may warrant further attention.
• Regulatory Compliance: Definitive Healthcare Corp. has fulfilled its disclosure obligations under Section 13 or 15(d) of the Securities Exchange Act of 1934, ensuring transparency regarding significant corporate events.

Other Corporate Details

• Company Identification: Central Index Key: 0001861795; SEC File Number: 1-40815.
• Fiscal Year End: December 31
• Business Contact: Phone: 508-720-4224
• Former Company Name: The company was previously known as “Definitive Healthcare” until May 12, 2021.

Conclusion

Investors should be aware of this leadership change, as board and committee reshuffles can indicate shifts in company strategy, governance, and risk management. While no immediate financial impact is disclosed, further updates on replacements or additional resignations could be of material interest. This news may influence the market perception of Definitive Healthcare Corp., especially in light of the importance of human capital management to technology and software companies.

Disclaimer:
The information provided here is based on Definitive Healthcare Corp.’s SEC Form 8-K filing dated March 30, 2026. This article is intended for informational purposes only and does not constitute investment advice. Investors are urged to consult official company disclosures and their financial advisors before making any investment decisions. The author does not own securities in Definitive Healthcare Corp. at the time of publication.

View Definitive Healthcare Corp. Historical chart here